9.35INR
267.21 MINR
2.37 BINR
7.93 M
About JAGSONPAL PHARMACE
Sector
CEO
Manish Gupta
Headquarters
Gurugram
Website
Employees (FY)
940
Founded
1978
ISIN
INE048B01027
FIGI
BBG000CTMHK8
Jagsonpal Pharmaceuticals Ltd. engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. It offers portfolio of drugs focusing on the gynaecology and orthopaedic segments. The company was founded by Jagmohan Singh Kochhar in 1978 and is headquartered in Gurugram, India.
#JAGSNPHARM Ready for a potential breakout !🌟PROS :
⭐️- Company is almost debt free.
⭐️-Company has delivered good profit growth of 35.2% CAGR over last 5 years
⭐️-Company has been maintaining a healthy dividend payout of 40.0%
⭐️-Company's working capital requirements have reduced from 46.6 days to 35.6 days
Technical View :
🌟- Base breako
Fourty percentage profit expected in one monthBest swing stock Fourty percentage profit expected in one month
JAGSNPHARM NSE BULLISHVIEW ABOVE 370 CMP 370.5JAGSNPHARM NSE is bullish if 370 holds. NEW LIFETIME High. Fresh Breakout. Positive Trend.
Disclaimer: Educational Purpose Only. Not Buy Sell Reco. Not Sebi Registered.
Jagsonpal Looks GoodChart Looks Good
Nice Consolidation
Delivery Quantity 14X times
High Chances there will be breakout
JAGSONPAL PHARMA AS ON 03.08.2021A GOOD CALL FROM MACD AND RSI !!
CAN MAKE A GOOD MOVE !!
MADE 100rs HIGH IN 3 MONTHS!!
TARGET PRICE= 3-4%
STOP LOSS= GO WITH TRAILING STOP LOSS OR 188/189!!
(THE ABOVE ANALYSIS IS JUST FOR STUDY PURPOSE DONT TAKE IT AS ANY BUY OR SELL CALL)
JAGSONPAL PHARMACE - My Hunch - could be ExplosiveNothing much to draw here.
A channel in which it has been moving and on the monthly Time Frame I see a breakout.
Long Term Wealth Creation Idea 2020 #4#JAGSNPHARM 43.8 | Accumulate with long term perspective upto 35 levels at least for 2x/3x+ gains...
Valuation | Dividend | P/E | P/B : Lucrative
Favorable Portfolio allocation : Upto 5% of Overall Capital
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of JAGSNPHARM is 317.40 INR — it has decreased by 1.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange JAGSONPAL PHARMACE stocks are traded under the ticker JAGSNPHARM.
JAGSONPAL PHARMACE is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
JAGSNPHARM stock is 3.23% volatile and has beta coefficient of 0.39. Check out the list of the most volatile stocks — is JAGSONPAL PHARMACE there?
Yes, you can track JAGSONPAL PHARMACE financials in yearly and quarterly reports right on TradingView.
JAGSNPHARM stock has risen by 7.96% compared to the previous week, the month change is a 10.04% rise, over the last year JAGSONPAL PHARMACE has showed a 12.08% decrease.
JAGSNPHARM net income for the last quarter is 39.63 M INR, while the quarter before that showed 74.72 M INR of net income which accounts for −46.96% change. Track more JAGSONPAL PHARMACE financial stats to get the full picture.
Today JAGSONPAL PHARMACE has the market capitalization of 8.51 B, it has increased by 1.01% over the last week.
Yes, JAGSNPHARM dividends are paid annually. The last dividend per share was 5.00 INR. As of today, Dividend Yield (TTM)% is 1.55%. Tracking JAGSONPAL PHARMACE dividends might help you take more informed decisions.
JAGSONPAL PHARMACE dividend yield was 1.72% in 2022, and payout ratio reached 49.02%. The year before the numbers were 1.28% and 55.58% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, JAGSNPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAGSONPAL PHARMACE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 940.00 employees. See our rating of the largest employees — is JAGSONPAL PHARMACE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JAGSONPAL PHARMACE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JAGSONPAL PHARMACE stock shows the buy signal. See more of JAGSONPAL PHARMACE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAGSONPAL PHARMACE EBITDA is 258.35 M INR, and current EBITDA margin is 14.95%. See more stats in JAGSONPAL PHARMACE financial statements.